Vest Financial, LLC has opened a new $15.9M position in $EXPE, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 12-31-2025 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $EXPE.
$EXPE Hedge Fund Activity
We have seen 552 institutional investors add shares of $EXPE stock to their portfolio, and 423 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- WELLINGTON MANAGEMENT GROUP LLP added 1,801,232 shares (+24899.5%) to their portfolio in Q3 2025, for an estimated $385,013,340
- JPMORGAN CHASE & CO added 1,223,297 shares (+34.3%) to their portfolio in Q3 2025, for an estimated $261,479,733
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP removed 742,380 shares (-73.5%) from their portfolio in Q3 2025, for an estimated $158,683,725
- VICTORY CAPITAL MANAGEMENT INC removed 737,245 shares (-20.4%) from their portfolio in Q3 2025, for an estimated $157,586,118
- AQR CAPITAL MANAGEMENT LLC added 728,063 shares (+25.0%) to their portfolio in Q3 2025, for an estimated $155,623,466
- THRIVENT FINANCIAL FOR LUTHERANS added 594,964 shares (+3638.0%) to their portfolio in Q3 2025, for an estimated $127,173,555
- CLEARBRIDGE INVESTMENTS, LLC removed 584,043 shares (-57.1%) from their portfolio in Q3 2025, for an estimated $124,839,191
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$EXPE Insider Trading Activity
$EXPE insiders have traded $EXPE stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $EXPE stock by insiders over the last 6 months:
- CRAIG A JACOBSON has made 0 purchases and 2 sales selling 6,000 shares for an estimated $1,437,978.
- ROBERT J DZIELAK (Chief Legal Officer & Sec'y) has made 0 purchases and 2 sales selling 5,964 shares for an estimated $1,210,381.
- LANCE A SOLIDAY (SVP & Chief Accounting Officer) has made 0 purchases and 3 sales selling 2,557 shares for an estimated $605,964.
- MADHUMITA MOINA BANERJEE sold 1,000 shares for an estimated $258,000
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$EXPE Analyst Ratings
Wall Street analysts have issued reports on $EXPE in the last several months. We have seen 7 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 01/06/2026
- B of A Securities issued a "Buy" rating on 12/19/2025
- Argus Research issued a "Buy" rating on 11/10/2025
- Goldman Sachs issued a "Buy" rating on 11/07/2025
- Benchmark issued a "Buy" rating on 11/07/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
- B. Riley Securities issued a "Buy" rating on 08/08/2025
To track analyst ratings and price targets for $EXPE, check out Quiver Quantitative's $EXPE forecast page.
$EXPE Price Targets
Multiple analysts have issued price targets for $EXPE recently. We have seen 22 analysts offer price targets for $EXPE in the last 6 months, with a median target of $283.0.
Here are some recent targets:
- Eric Sheridan from Goldman Sachs set a target price of $325.0 on 01/28/2026
- Trevor Young from Barclays set a target price of $245.0 on 01/21/2026
- Brian Nowak from Morgan Stanley set a target price of $270.0 on 01/13/2026
- Naved Khan from B. Riley Securities set a target price of $360.0 on 01/12/2026
- Ken Gawrelski from Wells Fargo set a target price of $329.0 on 01/09/2026
- Richard Clarke from Bernstein set a target price of $256.0 on 01/06/2026
- Jake Fuller from BTIG set a target price of $330.0 on 01/06/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $EXPE ticker page for more data.